Xencor (XNCR) Research & Development (2013 - 2026)

Xencor's (XNCR) quarterly Research & Development came in at $64.7 million in Q1 2026, up 10.4% year-on-year from $58.6 million in Q1 2025, and little changed on a QoQ basis from $64.8 million in Q4 2025.

Xencor (XNCR) Research & Development (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Research & Development data on file, last reported at $64.7 million in Q1 2026.

  • On a quarterly basis, Research & Development rose 10.4% year-over-year to $64.7 million in Q1 2026; TTM through Mar 2026 was $245.5 million, a 7.03% increase from a year earlier, with the FY2025 full-year figure at $239.4 million, up 5.16% from the prior year.
  • Research & Development for Q1 2026 stood at $64.7 million, roughly flat from $64.8 million in the prior quarter.
  • Over the last five years, Research & Development for XNCR reached as high as $64.9 million in Q3 2023 and fell as low as $47.1 million in Q2 2022.
  • Historically, Research & Development has averaged $57.9 million across 5 years, with a median of $58.6 million in 2025.
  • Across the five-year window, Research & Development surged 34.81% in 2023 and decreased 20.5% in 2024, its largest moves.
  • Year by year, Research & Development stood at $51.5 million in 2022, then climbed by 24.82% to $64.2 million in 2023, then decreased by 20.5% to $51.1 million in 2024, then increased by 26.97% to $64.8 million in 2025, then dropped by 0.24% to $64.7 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $64.7 million in Q1 2026, $64.8 million in Q4 2025, and $54.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -17.94 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 541.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -2.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.66 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.37 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 343.97 Mn
10 Xencor 1.47 Bn 1.09 Bn - 64.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 64.67 Mn
Dec 31, 2025 64.82 Mn
Sep 30, 2025 54.37 Mn
Jun 30, 2025 61.67 Mn
Mar 31, 2025 58.58 Mn
Dec 31, 2024 51.06 Mn
Sep 30, 2024 58.23 Mn
Jun 30, 2024 61.53 Mn
Mar 31, 2024 56.87 Mn
Dec 31, 2023 64.22 Mn
Sep 30, 2023 64.94 Mn
Jun 30, 2023 60.06 Mn
Mar 31, 2023 64.38 Mn
Dec 31, 2022 51.45 Mn
Sep 30, 2022 53.27 Mn
Jun 30, 2022 47.08 Mn
Mar 31, 2022 47.76 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 50.61 Mn
Jun 30, 2021 49.50 Mn